S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Stock market today: Another winning week for Wall Street ends with more records
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
One year after buying a failed bank, New York Community Bancorp is struggling
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
Critical asset just had biggest fall on record (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Stock market today: Another winning week for Wall Street ends with more records
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
One year after buying a failed bank, New York Community Bancorp is struggling
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
Critical asset just had biggest fall on record (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Stock market today: Another winning week for Wall Street ends with more records
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
One year after buying a failed bank, New York Community Bancorp is struggling
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
Critical asset just had biggest fall on record (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Stock market today: Another winning week for Wall Street ends with more records
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
One year after buying a failed bank, New York Community Bancorp is struggling
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
Critical asset just had biggest fall on record (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
NASDAQ:QLGN

Qualigen Therapeutics (QLGN) Stock Price, News & Analysis

$0.45
-0.01 (-2.18%)
(As of 03/1/2024 ET)
Today's Range
$0.44
$0.48
50-Day Range
$0.45
$0.58
52-Week Range
$0.44
$1.38
Volume
76,214 shs
Average Volume
52,477 shs
Market Capitalization
$2.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Qualigen Therapeutics MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.62% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.94mentions of Qualigen Therapeutics in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.70) to ($1.00) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.75 out of 5 stars


QLGN stock logo

About Qualigen Therapeutics Stock (NASDAQ:QLGN)

Qualigen Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a patent-protected rapid, onsite immunoassay testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, an oligonucleotide-based drug candidate to treat various nucleolin-expressing cancers, including liquid and solid tumors; QN-165, a drug candidate for the potential broad-spectrum treatment of infectious diseases, such as COVID-19; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and selective target antigen removal system, a therapeutic device to remove circulating tumor cells, viruses, inflammation factors, and immune checkpoints. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

QLGN Stock Price History

QLGN Stock News Headlines

Qualigen Therapeutics (NASDAQ:QLGN) Stock Price Down 15.3%
Qualigen Therapeutics Inc Ordinary Shares QLGN
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Qualigen Therapeutics Inc (QLGN)
QLGN: Dosing Begins in Phase 1 Trial of QN-302…
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Qualigen Therapeutics Inc (7R9.DU)
QLGN: Data for Pan-RAS Platform Presented at ASCO…
QLGN: IND for QN-302 to be Submitted in Mid-2023…
See More Headlines
Receive QLGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Qualigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/15/2023
Today
3/01/2024
Next Earnings (Estimated)
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:QLGN
Fax
N/A
Employees
31
Year Founded
N/A

Profitability

Net Income
$-18,640,000.00
Net Margins
-233.25%
Pretax Margin
-342.41%

Debt

Sales & Book Value

Annual Sales
$4.98 million
Book Value
$2.08 per share

Miscellaneous

Free Float
4,881,000
Market Cap
$2.32 million
Optionable
Not Optionable
Beta
-0.76

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives















QLGN Stock Analysis - Frequently Asked Questions

How have QLGN shares performed in 2024?

Qualigen Therapeutics' stock was trading at $0.55 at the start of the year. Since then, QLGN stock has decreased by 18.4% and is now trading at $0.4488.
View the best growth stocks for 2024 here
.

When is Qualigen Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our QLGN earnings forecast
.

How were Qualigen Therapeutics' earnings last quarter?

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) issued its quarterly earnings results on Tuesday, August, 15th. The company reported ($0.69) EPS for the quarter, missing analysts' consensus estimates of ($0.52) by $0.17. The business had revenue of $1.63 million for the quarter, compared to analyst estimates of $1.60 million. Qualigen Therapeutics had a negative trailing twelve-month return on equity of 479.72% and a negative net margin of 233.25%.

What other stocks do shareholders of Qualigen Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Qualigen Therapeutics investors own include iBio (IBIO), Boeing (BA), Sorrento Therapeutics (SRNE), T2 Biosystems (TTOO), NIO (NIO), NVIDIA (NVDA), Riot Platforms (RIOT), Vaxart (VXRT), Boxlight (BOXL) and Enphase Energy (ENPH).

Who are Qualigen Therapeutics' major shareholders?

Qualigen Therapeutics' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Amy S Broidrick, Christopher L Lotz, Kurt H Kruger and Michael S Poirier.
View institutional ownership trends
.

How do I buy shares of Qualigen Therapeutics?

Shares of QLGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:QLGN) was last updated on 3/2/2024 by MarketBeat.com Staff